Physician profile
Gregory S Cooper
NPI 1952320806
$20,402.61
in general payments reported to CMS, 2019-2025
15 companies · $2,541 in 2025
The $2,541 reported for 2025 was more than what 84% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,710 · 2020: $203 · 2021: $416 · 2022: $320 · 2023: $3,311 · 2024: $6,902 · 2025: $2,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,150.00 |
| Food and Beverage | $603.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $12,310.09 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $6,492.40 | 2019 | |
| Abbvie INC. | $909.26 | 2019-2025 | Skyrizi, Rinvoq, Viberzi |
| Takeda Pharmaceuticals U.S.A., INC. | $315.24 | 2019-2021 | |
| Janssen Biotech, INC. | $132.83 | 2020-2025 | Talvey, Darzalex |
| Nestle Healthcare Nutrition INC. | $57.21 | 2020-2021 | |
| Lilly USA, LLC | $55.03 | 2024-2025 | Omvoh |
| Ferring Pharmaceuticals INC. | $29.13 | 2021 | |
| Alnylam Pharmaceuticals INC. | $21.10 | 2023 | Givlaari |
| Merck Sharp & Dohme LLC | $20.00 | 2022 | |
| Qol Medical, LLC | $16.85 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.88 | 2021 | |
| Shire North American Group INC | $14.52 | 2019 | |
| Allergan, INC. | $13.07 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.